The thing that gets me about this one is how logical the misattribution feels. Of course you're exhausted — you're in perimenopause. Of course your brain is foggy — hormones. It took a routine blood test to reveal that the fatigue had a second, very treatable cause sitting right underneath the hormonal noise. If this story sounds familiar, please push for a ferritin test. Not just a standard hemoglobin check — ferritin.
Learn more about Rose →In perimenopause, anovulatory cycles — months where ovulation doesn't occur — commonly produce prolonged, unpredictably heavy bleeding due to unopposed estrogen stimulating the uterine lining. Losing more than 80ml of blood per cycle is clinically defined as heavy menstrual bleeding, and perimenopausal women frequently exceed this threshold without realizing it because their baseline has shifted so gradually. Each episode removes iron at a rate the gut simply cannot absorb fast enough to compensate, meaning stores erode over months or years before clinical anemia appears on a standard test.
Iron deficiency exists on a spectrum: ferritin (stored iron) falls first, serum iron drops next, and frank anemia — low hemoglobin — comes last. Most routine blood panels in primary care check hemoglobin but not ferritin, which means a woman can be functionally iron-depleted and symptomatic for a long time before any abnormality shows up on a standard CBC. Requesting a ferritin level specifically closes this diagnostic gap, yet it remains an underused step in perimenopausal care.
Fatigue is one of the most reported symptoms of perimenopause, driven by disrupted sleep, night sweats, and hormonal fluctuation — and it is also the primary symptom of iron deficiency anemia. When a woman is already expecting to feel tired because she is perimenopausal, worsening exhaustion rarely triggers alarm; it simply reinforces the narrative she has already been given. This attribution bias is not a personal failing — it is a predictable consequence of two conditions sharing the same leading symptom at exactly the same life stage.
Estrogen fluctuation reduces cerebral glucose metabolism and affects neurotransmitter signaling, producing the well-documented cognitive dulling of perimenopause. Iron deficiency independently impairs cognitive function because iron is essential for dopamine synthesis and myelin maintenance in the brain. Without a ferritin test, there is no clinical way to know how much of the brain fog is hormonal and how much is driven by depleted iron — and treating one cause while missing the other means only partial recovery at best.
Palpitations are a recognized perimenopausal symptom, linked to estrogen's effects on cardiac conduction and autonomic nervous system changes. However, iron deficiency anemia causes compensatory tachycardia because the heart must beat faster to deliver adequate oxygen when red blood cells are reduced or underfilled. A woman who mentions palpitations to her doctor in the context of perimenopause is statistically more likely to have them attributed to hormones than to have her iron status investigated.
Feeling winded climbing stairs or during light exercise is not a typical estrogen-withdrawal symptom, yet perimenopausal women who mention it often have it dismissed as deconditioning, anxiety, or general 'hormonal' malaise. Iron deficiency anemia reduces oxygen-carrying capacity directly, and exertional breathlessness is one of its most specific signs. The connection between this symptom and the heavy periods happening simultaneously is not consistently made in clinical consultations, particularly when the woman herself has normalized her bleeding as a perimenopause feature.
When periods arrived predictably every 28 days, tracking flow and estimating total monthly blood loss was relatively straightforward. In perimenopause, cycles may arrive every 19 days or every 47 days, making it genuinely difficult to assess how much blood has been lost over a three-month window. A woman who bleeds heavily every three weeks is losing far more iron annually than her premenopausal self did — but the irregularity obscures this arithmetic unless someone explicitly calculates it.
Restless legs syndrome (RLS) has a well-established mechanistic link to low iron: the dopaminergic pathways in the spinal cord that regulate leg movement sensation require adequate iron to function, and ferritin below approximately 50–75 µg/L is associated with RLS symptom onset or worsening. Perimenopausal women experience sleep disruption for multiple hormonal reasons, and an emerging or worsening creeping sensation in the legs at night is frequently absorbed into that general sleep complaint rather than triggering iron investigation. Asking specifically about RLS symptoms and checking ferritin together is a diagnostically efficient pairing.
Research consistently shows that many primary care providers receive limited training in menopause medicine, which means the nuanced overlap between hormonal symptoms and comorbid iron deficiency is not always on the clinical radar. A perimenopausal woman presenting with fatigue, brain fog, and heavy periods may receive a hormone conversation without any investigation of her iron status — not through negligence, but through a framework that treats the bleeding and the symptoms as part of the same hormonal story rather than as two distinct processes requiring separate workup. Advocating for a full iron panel including ferritin, alongside any hormonal evaluation, is a reasonable and evidence-supported ask.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.